Selecting Medication for Depression: Do Genomics Matter? - Frankly Speaking Ep 304

<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304</a></p> <p>Overview: Pharmacogenomic testing has been suggested as a way to personalize medicine, particularly where the metabolism of medications can vary significantly. Unfortunately, despite increasing use of this testing, there has been little evidence showing a benefit in clinical outcomes. Listen to this podcast to explore the data on clinical outcomes for pharmacogenetic testing and how to best select medication for patients with depression.</p> <p>Episode resource links:</p> <ul><li>Oslin DW, Lynch KG, Shih MC, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022;328(2):151-161.</li> </ul> <p>Guest: Alan Ehrlich MD, FAAFP   Music Credit: Richard Onorato</p>